Acute Lymphoblastic Leukemia: Risk Stratification
1 Bekeken
administrator
06/15/23
Mark R. Litzow, MD; Ryan D. Cassaday, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Anthony S. Stein, MD, reflect on the complexities of the risk stratification process in acute lymphoblastic leukemia, incorporating patient age, molecular subtype, and minimal residual disease status.
Laat meer zien
Facebook Reacties
Geen reacties gevonden